ライフサイエンスコーパス: oxygenator

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 on system composed of a pump, reservoir, and oxygenator.

2 g was commenced to prevent thrombosis of the oxygenator.

3 uidic device with an integrated differential oxygenator.

4 le blood from human volunteers on a membrane oxygenator.

5 ent circuit and passed it through a membrane oxygenator.

6 usting the CO2 gas flow through the membrane oxygenator.

7 A membrane oxygenator (0.65 m) was inserted within the hemofiltrati

8 The different types of membrane oxygenators and pumps did not significantly alter hemost

9 consisted of a centrifugal pump, a membrane oxygenator, and a heat exchanger.

10 m consisted of a blood reservoir, a membrane oxygenator, and a nonocclusive roller pump.

11 ediately proximal and distal to the membrane oxygenator at 5 mins, 1 hr, and 3 hrs after the start of

12 AVCO2R was implanted using a hollow-fiber oxygenator attached to 12 F and 14 F vascular cannulas t

13 The oxygenator blood flow (p <0.001) and the CO2 removal rat

14 ated using a bespoke extracorporeal membrane oxygenator circuit before return to the donor.

15 ent of a system that incorporates a pumpless oxygenator circuit connected to the fetus of a lamb via

16 The prototype oxygenator, consisting of cross-wound silicone hollow fi

17 The use of the extracorporeal membrane oxygenator (ECMO) for postoperative cardiac patients has

18 ntinuation relies on extracorporeal membrane oxygenator (ECMO).

19 The flow from the membrane oxygenator either returned directly to the patient circu

20 spent more hours on extracorporeal membrane oxygenator; had significantly higher heparin-induced thr

21 Closed system circuits using a membrane oxygenator have partially met these requirements but hav

22 uction of arterial-line filters and membrane oxygenators, have led to a reduction of both microemboli

23 olume and a new high-efficiency hollow-fiber oxygenator in a circuit with a check valve flow control

24 e is no uptake of morphine onto the membrane oxygenator of the ECMO circuit.

25 ted thrombosis among extracorporeal membrane oxygenator patients at our institution is relatively hig

26 d high-risk group of extracorporeal membrane oxygenator patients may be needed.

27 Ninety-six extracorporeal membrane oxygenator patients met the inclusion criteria.

28 optimal strategy in extracorporeal membrane oxygenator patients.

29 prospectively on all extracorporeal membrane oxygenator patients.

30 ed for 2 hours in an extracorporeal membrane oxygenator perfusion circuit at 37 degrees C.

31 bolic event while on extracorporeal membrane oxygenator (prevalence of heparin-induced thrombocytopen

32 cuit was established by using a hollow fiber oxygenator, primed with maternal sheep blood (150-200 mL

33 On an average of both positions, the oxygenator's blood flow was 410 +/- 30 mL/min and the CO

34 derwent venoarterial extracorporeal membrane oxygenator; spent more hours on extracorporeal membrane

35 was injected just downstream of the membrane oxygenator; the lithium ion concentration-time curves we

36 ngle-piston, nonporous hollow silicone fiber oxygenator to adequately support gas exchange, allowing

37 Oxygen was attached to the oxygenator to provide the sweep gas.

38 nd in the flow just upstream of the membrane oxygenator using lithium selective electrodes.

39 te (p = 0.083) were higher when the membrane oxygenator was placed upstream of the hemofilter.

40 Oxygen delivery by the oxygenator was significantly increased at Fio2 of 0.10,

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。